UNSPSC 51332527: Trifluperidol hydrochloride

This classification denotes an antipsychotic agent with the molecular formula C22H23F4NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UIC8RB6P81, chemically known as 4-fluoro-4-(4-hydroxy-4-(alpha,alpha,alpha-trifluoro-m-tolyl)piperidino)butyrophenone but more generally known as trifluperidol hydrochloride, which bears US NIH Compound Identifier 5567. European Medicines Agency schedules Trifluperidol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04957MIG.

Most nations, for tariff and trade purposes, schedule trifluperidol hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, TRIFLUPERIDOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C1CC(CC(C1)C(F)(F)F)C2(CCN(CC2)CCCC(=O)C3CCC(CC3)F)O.CL.

UNSPSC 51332527 Trifluperidol hydrochloride is a Commodity code representing pharmaceutical products, though recent state and local solicitation activity under this code shows a mismatch with its nominal scope. The single recent opportunity in the dataset — Seminole County, Florida's IFB60459723LAS — solicits naloxone and safe drug deactivation systems, which fall outside the trifluperidol hydrochloride category. State and local governments purchasing under this code appear to procure specialized pharmaceuticals and related health-support products, but the available record provides limited visibility into the broader buying patterns or issuing-body mix that typically use this Commodity designation.

Seminole County, a Florida county government, posted the most recent relevant solicitation on June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding. Deliveries are required quarterly to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping costs. The contract carries a two-year initial term with a one-year renewal option and includes standard compliance requirements such as drug-free workplace certification, E-Verify enrollment, and specific insurance coverage. The procurement may be FEMA-funded, introducing federal regulatory compliance obligations. Beyond this single opportunity, the dataset provides no additional recent activity under the trifluperidol hydrochloride code to characterize geographic spread, repeat buyers, or broader solicitation patterns across state and local jurisdictions.